Adil A. Sayyed

Ghandinagar, GJ 380054, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.

Journal: Molecular pharmaceutics

Published: February 16, 2026

CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept study.

CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept study.

Journal: Molecular therapy. Oncology

Published: November 21, 2025

Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.

Imidazopyrimidine-based pyruvate kinase M2 activator halts diabetic nephropathy progression via modulating epithelial-to-mesenchymal transition and fibrosis.

Journal: Chemico-biological interactions

Published: March 10, 2025

Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy.

Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 04, 2023

Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation.

Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation.

Journal: Nanomaterials (Basel, Switzerland)

Published: September 12, 2023

Extracellular vesicle RNA signaling in the liver tumor microenvironment.

Extracellular vesicle RNA signaling in the liver tumor microenvironment.

Journal: Cancer letters

Published: December 02, 2022

Correction: Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Correction: Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Journal: Molecular neurobiology

Published: October 14, 2022

AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.

AMPK-dependent autophagy activation and alpha-Synuclein clearance: a putative mechanism behind alpha-mangostin's neuroprotection in a rotenone-induced mouse model of Parkinson's disease.

Journal: Metabolic brain disease

Published: July 12, 2022

Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Chlorogenic Acid: a Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson's Disease by GLP-1 Secretion.

Journal: Molecular neurobiology

Published: April 04, 2022

Mesenchymal Stem Cell-Derived Exosomes Loaded with miR-155 Inhibitor Ameliorate Diabetic Wound Healing.

Mesenchymal Stem Cell-Derived Exosomes Loaded with miR-155 Inhibitor Ameliorate Diabetic Wound Healing.

Journal: Molecular pharmaceutics

Published: March 16, 2022

Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment.

Extracellular vesicle‑mediated miR‑126‑3p transfer contributes to inter‑cellular communication in the liver tumor microenvironment.

Journal: International journal of oncology

Published: February 05, 2022

MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.

MiR-155 Inhibitor-Laden Exosomes Reverse Resistance to Cisplatin in a 3D Tumor Spheroid and Xenograft Model of Oral Cancer.

Journal: Molecular pharmaceutics

Published: June 28, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026